A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age.

Autor: Susarla SK; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, India., Narang M; Department of Pediatrics, Guru Teg Bahadur Hospital, Delhi, India., Khandgave PN; Department of Pediatrics, Pulse Multispecialty Hospital, Pune, India., Patnaik L; Department of Community Medicine, IMS & SUM Hospital, Siksha 'O' Anusandhan deemed to be University, Bhubaneswar, India., Rajapantula V; Department of Medicine, King George Hospital, Visakhapatnam, India., M S; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, India., Bc R; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, India., Sahoo DP; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, India., Kanakasapapathy AK; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, India.

Publikováno v: Infectious diseases (London, England) [Infect Dis (Lond)] 2024 Oct 08, pp. 1-15. Date of Electronic Publication: 2024 Oct 08.